Skip to main content
. 2023 Aug 16;15(16):7933–7955. doi: 10.18632/aging.204862

Figure 6.

Figure 6

Investigation of the variation in immunotherapy across mTORC1-related subgroups. (A, B) The boxplots illustrate the immune checkpoints that were upregulated in C1 in comparison with C2 in TCGA-LIHC and ICGC-LIRI-JP cohorts. (C) Variations in the TIDE score and immune response status of the diverse molecular subtypes in the TCGA-LIHC cohort. (D) Variations in the TIDE score and immune response status of the diverse molecular subtypes in the ICGC-LIRI-JP cohort.